Clinical Trial Update: Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression [NA]

View source ↗

Summary

This ongoing clinical trial explores whether virtual reality eye tracking can help identify schizophrenia, bipolar disorder, and major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Snippet

Sponsor: Etablissement Public de Santé Barthélemy Durand | Conditions: Psychiatric Disorders (Diagnosis) | NA | Status: ACTIVE_NOT_RECRUITING